Amphastar Pharmaceuticals, Inc. Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Amphastar Pharmaceuticals, Inc. (AMPH) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $45.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2022-03-11
- Amphastar Pharmaceuticals, Inc. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2019 was $45.00K, a 64.29% decline from fiscal 2018.
- Amphastar Pharmaceuticals, Inc. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2018 was $126.00K.
- Amphastar Pharmaceuticals, Inc. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2013 was $93.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2019-12-31 | $45.00K 10-K · filed 2022-03-11 |
| 2018-12-31 | $126.00K 10-K · filed 2021-03-15 |
| 2013-12-31 | $93.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |